BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38069847)

  • 1. INFLUENCE OF THE PATIENT'S SEX AND AGE, VOLUMES OF THE SALIVARY GLAND AND PLEOMORPHIC ADENOMA ON THE TUMOR HISTOLOGICAL VARIANTS.
    Brodetskyi IS; Malanchuk VA; Myroshnychenko MS; Riebienkov SO; Arseniev OV; Kotenko OE; Brodetska LO
    Pol Merkur Lekarski; 2023; 51(5):475-481. PubMed ID: 38069847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MORPHOLOGICAL CHARACTERISTICS OF PLEOMORPHIC ADENOMAS OF SALIVARY GLANDS (ANALYSIS OF THE SURGICAL MATERIAL).
    Brodetskyi IS; Dyadyk OO; Myroshnychenko MS; Zaritska VI
    Wiad Lek; 2020; 73(11):2339-2344. PubMed ID: 33454664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXPRESSION FEATURES OF HUMAN PAPILLOMA VIRUS TYPE 16 AND ANTI-EPSTEIN-BARR VIRUS IN PLEOMORPHIC ADENOMA, SURROUNDING AND INTACT SALIVARY GLAND.
    Brodetskyi IS; Malanchuk VA; Dyadyk OO; Myroshnychenko MS; Kulbashna YА; Astapenko OO; Feleshtynska OI; Kapustnyk NV; Kalashnyk-Vakulenko YM
    Wiad Lek; 2021; 74(8):1789-1793. PubMed ID: 34537721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AN INTEGRATED APPROACH TO THE MORPHOLOGICAL DIAGNOSIS OF DIFFERENT TYPES OF PLEOMORPHIC ADENOMAS OF THE SALIVARY GLAND: LONG-TERM RESEARCH RESULTS.
    Myroshnychenko MS; Brodetskyi IS; Malanchuk VA; Dyadyk OO; Arseniev OV; Kulbashna YА; Astapenko OO; Brodetska LO; Brodetskyi SB; Bibichenko VO
    Wiad Lek; 2022; 75(7):1673-1677. PubMed ID: 35962679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNOHISTOCHEMICAL FEATURES OF THE EXPRESSION OF HUMAN PAPILLOMA VIRUS TYPE 16 IN PLEOMORPHIC ADENOMAS OF SALIVARY GLAND.
    Brodetskyi IS; Dyadyk OO; Malanchuk VA; Myroshnychenko MS; Krotevych MS
    Wiad Lek; 2021; 74(1):7-10. PubMed ID: 33851578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging and Histopathology in a Case of Pleomorphic Adenoma of a Minor Salivary Gland in the Nasal Cavity.
    Kajiyama A; Edo H; Inoue N; Yokouchi Y; Gomi T
    Am J Case Rep; 2019 May; 20():679-684. PubMed ID: 31079138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
    Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
    Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic adenoma of the salivary glands: correlation between gallium-67 uptake and histopathological components.
    Yoshikai T; Yonemitsu N; Ishimaru J; Mihara M; Shin T; Kudo S
    J Nucl Med; 1998 Mar; 39(3):537-41. PubMed ID: 9529306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.
    Kato H; Kawaguchi M; Ando T; Mizuta K; Aoki M; Matsuo M
    Jpn J Radiol; 2018 Aug; 36(8):463-471. PubMed ID: 29845358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Primary Pleomorphic Adenoma in Posterior Fossa.
    Yang L; Tan L; Lau Q; Jayalath R
    World Neurosurg; 2016 Sep; 93():484.e5-8. PubMed ID: 27465421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological study of pleomorphic adenoma of salivary glands.
    Enescu AŞ; Enescu A; Bălăşoiu M; Ciolofan MS; Căpitănescu AN
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1149-53. PubMed ID: 25607398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of BMP6 marker within the process of epithelial-mesenchymal transition in the pleomorphic adenoma of the salivary gland.
    Enescu AŞ; Enescu A; Căpitănescu AN; Mitroi MR; Pădureanu V; Dumitrescu EM; Albulescu DM; Ciurea ME
    Rom J Morphol Embryol; 2017; 58(1):145-151. PubMed ID: 28523310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
    Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
    Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUMORS AND TUMOR-LIKE LESIONS OF THE SALIVARY GLANDS: MORPHOLOGICAL CHARACTERISTICS OF THE SURGICAL MATERIAL.
    Brodetskyi IS; Malanchuk VA; Sorokin BV; Myroshnychenko MS; Beketova YI; Dyadyk OO; Kapustnyk NV; Krotevych MS; Brodetskyi SB
    Wiad Lek; 2021; 74(4):929-933. PubMed ID: 34156006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
    Martins C; Fonseca I; Roque L; Pereira T; Ribeiro C; Bullerdiek J; Soares J
    Mod Pathol; 2005 Aug; 18(8):1048-55. PubMed ID: 15920557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours.
    Hellquist H; Paiva-Correia A; Vander Poorten V; Quer M; Hernandez-Prera JC; Andreasen S; Zbären P; Skalova A; Rinaldo A; Ferlito A
    Adv Ther; 2019 Aug; 36(8):1950-1974. PubMed ID: 31209701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma.
    Terra GT; Oliveira JX; Hernandez A; Lourenço SV; Arita ES; Cortes AR
    Dentomaxillofac Radiol; 2017 Jan; 46(1):20160257. PubMed ID: 27845594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MORPHOLOGICAL JUSTIFICATION OF THE SALIVARY GLAND TISSUE RESECTION BOUNDARIES DURING SURGICAL TREATMENT OF PATIENTS WITH PLEOMORPHIC ADENOMAS.
    Brodetskyi IS; Malanchuk VA; Dyadyk OO; Kulbashna YА; Astapenko OO; Kapustnyk NV; Myroshnychenko MS
    Wiad Lek; 2021; 74(9 cz 1):2182-2186. PubMed ID: 34725297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.
    Silva LP; Santana T; Sedassari BT; de Sousa SM; Sobral APV; Freitas RA; Barboza CAG; de Souza LB
    Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3203-3209. PubMed ID: 28523411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.